Phage Therapy of Vibrio Harveyi 41Sundar, M.M., G.S. Nagananda, A. Das, S. Bhattacharya, S. Suryan, 2009.
Isolation of host-specific bacteriophages from sewage against human
pathogens. Asian J. Biotechnol., 1: 163 – 170.
Stahl, F.W. (1998). Recombination in phage lambda: one geneticist’s
historical perspective. Gene. 223: 95-102.
Wall, S.K., Zhang, J., Rostagno, M.H., and Ebner, P.D. (2010). Phage therapy
to reduce preprocessing Salmonella infections in market-weight swine.
Appl Environ Microbiol. 76: 48-53.
Wang, J., Hu, B. Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L.,
Gong, J., Li, Q.Q., and Hu, J. (2006). Use of bacteriophage in the
treatment of experimental animal bacteremia from imipenem-resistant
Pseudomonas aeruginosa. Int. J. Mol. Med. 17: 309-317.
Wolf, S.E., and Woodside, K.J. (2005). Transgenic and gene knock-out
techniques and burn research. J. Surg. Res. 123: 328-39.
Zhou J, Fang W, Yang X, Zhou S, Hu L, Li X, Qi X, Su H, Xie L. (2012). A
nonluminescent and highly virulent Vibrio harveyi strain is associated
with "bacterial white tail disease" of Litopenaeus vannamei shrimp. PLoS
One. 7(2):e29961.